Concepedia

Isabel Waibel

IW

1

Publications

13

Citations

1

H-Index

2024

Active since

Affiliations

Novo Nordisk (United States)(Current)

Isabel Waibel is an author at Novo Nordisk (United States).

ORCID

Publications per year

2024–2024

1

Publications

1

A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructs

Itzel Condado Morales, Fabian Dingfelder, Isabel Waibel et al. · mAbs · 2024 · 13 citations · Full text

Rows per page

1–1 of 1